Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuwa (扶娃) is an approved nutritional supplement oral liquid developed and marketed by Guangdong Hongshanhu Pharmaceutical (also known as Guangdong Red Coral Pharmaceutical). The product, known generically as Calcium Gluconate and Zinc Oral Solution, is a combination of two essential minerals formulated for oral administration. It is primarily indicated for the treatment and prevention of calcium and zinc deficiencies, with a strong emphasis on pediatric use to support growth and development. As a mineral supplement, it functions by directly providing elemental calcium and zinc, which are vital for bone mineralization, immune system maintenance, and the function of numerous enzymes. The product does not have a specific molecular pharmacologic target, acting instead through systemic mineral replenishment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuwa Calcium Gluconate and Zinc Oral Solution.